Understanding Immunity to the Flu Vaccine in COVID-19 Patients

Recruiting

I'm Interested

Trial ID: NCT04579588

Age - 18 Years-64 Years Gender - ALL Accepting Healthy Volunteers - yes

Purpose

The purpose of this study is to measure immunity to the flu vaccine over time in patients who had COVID-19. Adults who have been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.

Official Title

Understanding Immunity to the Flu Vaccine in COVID-19 Patients

Stanford Investigator(s)

Sayantani Sindher

Clinical Associate Professor, Medicine Clinical Associate Professor, Pediatrics - Allergy and Clinical Immunology

Eligibility

Inclusion Criteria:

* Adults enrolled in study 55689 (NCT04373148) or the general population
* Adults diagnosed with severe or moderate COVID-19 at least 2 months prior enrollment
* Adults without COVID-19 diagnosis for controls

Exclusion Criteria:

* Received the influenza vaccine less than 4 months ago
* Pregnant or lactating
* Patients with special risks attendant to venipuncture
* Use of immunomodulatory medications
* Immunodeficiency or autoimmune disease

View More
View Less

Intervention(s):

biological: Flu shot

Recruiting

I'm Interested

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
SNP Center Inquiry
650-521-7237

©2024 Stanford Medicine